Literature DB >> 26290562

Chronic myeloid leukaemia with extreme thrombocytosis.

Shailendra Prasad Verma1, Arunkumar Subbiah2, Sajini Elizabeth Jacob3, Debdatta Basu3.   

Abstract

We report two cases of chronic myeloid leukaemia (CML) with extreme thrombocytosis. The first patient was a 65-year-old man who presented with prolonged history of upper abdominal discomfort, anorexia and two episodes of recent gum bleeds without fever or other bleeding manifestations. He was a chronic smoker with no other comorbidities. Examination revealed moderate hepatosplenomegaly. On investigation, he was found to have extreme thrombocytosis (3,500,000/mm(3)) and leucocytosis with moderate anaemia. In view of the leucocytosis, he was investigated for CML and found to be positive for BCR-ABL by reverse transcription PCR (RT-PCR). He received imatinib 400 mg/day and achieved complete haematological response at the end of 3 months. The second patient was a 7-year-old boy who presented with fever, cough and cold of 2-week duration. Examination revealed mild hepatomegaly with palpable spleen tip. Haemogram and peripheral smear revealed moderate leucocytosis with extreme thrombocytosis (2,800,000/mm(3)). On evaluation, he was found to be BCR-ABL positive and responded well to imatinib treatment. In both these cases, massive thrombocytosis was an unusual presentation of a well-known entity, namely, CML. This degree of thrombocytosis is usually seen only in essential thrombocytosis. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26290562      PMCID: PMC4550973          DOI: 10.1136/bcr-2014-204564

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  [Chronic myeloid leukemia onset with marked thrombocythemia].

Authors:  Qun Shen; Jian-Wei Zhou; Guang-Rong Zhu; Yue-Yan Yang; Hai-Rong Qiu; Guang-Rong Zhu; Wen Xia; Peng-Jun Jiang
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2006-04

2.  Chronic myeloid leukemia with extreme thrombocytosis.

Authors:  So Young Kim; You La Jeon; Tae Sung Park
Journal:  Korean J Hematol       Date:  2012-03-28

3.  Elevated platelet count features the variant type of BCR/ABL junction in chronic myelogenous leukaemia.

Authors:  T Yamagata; K Mitani; Y Kanda; Y Yazaki; H Hirai
Journal:  Br J Haematol       Date:  1996-08       Impact factor: 6.998

4.  Every case of essential thrombocythemia should be tested for the Philadelphia chromosome.

Authors:  Lawrence Rice; Uday Popat
Journal:  Am J Hematol       Date:  2005-01       Impact factor: 10.047

Review 5.  Philadelphia (Ph) chromosome-positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood: natural history and diagnostic differentiation from Ph-negative essential thrombocythemia.

Authors:  Jan Jacques Michiels; Zwi Berneman; Wilfried Schroyens; Jack Kutti; Birgitta Swolin; Börje Ridell; Pagani Fernando; Ulises Zanetto
Journal:  Ann Hematol       Date:  2004-05-26       Impact factor: 3.673

6.  Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular Monitoring.

Authors:  Stephen E Langabeer; Sarah L McCarron; Johanna Kelly; Janusz Krawczyk; Suzanne McPherson; Kanthi Perera; Philip T Murphy
Journal:  Case Rep Hematol       Date:  2012-07-02
  6 in total
  1 in total

1.  Analysis of clinical characteristics and efficacy of chronic myeloid leukemia onset with extreme thrombocytosis in the era of tyrosine kinase inhibitors.

Authors:  Zhihe Liu; Hongqiong Fan; Yuying Li; Chunshui Liu
Journal:  Onco Targets Ther       Date:  2017-07-17       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.